21st Century Oncology Inc:企業の戦略的SWOT分析

◆英語タイトル:21st Century Oncology Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C15786
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

21st Century Oncology Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

21st Century Oncology Inc (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services. It provides radiation therapy and integrated cancer care services to patients. The company has affiliations with physicians specializing in the areas of medical oncology, urology, gynecological, breast and surgical oncology, general surgery, radiation oncology, and primary care. It also offers specialized delivery systems for internal beam radiation therapy. The company operates through international treatment centers operations in the US and in certain Latin American markets. 21st Century Oncology is headquartered in Fort Myers, Florida, the US.

21st Century Oncology Inc Key Recent Developments

Mar 14,2019 21st Century Oncology bolsters its best-in-class Oncology dream team by adding five nationally renowned physicians
Jan 07,2019 21st Century Oncology hires Powell as chief operating officer
Apr 18,2018 21st Century Oncology Names Kimberly Commins-Tzoumakas As Chief Executive Officer

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
21st Century Oncology Inc – Key Facts
21st Century Oncology Inc – Key Employees
21st Century Oncology Inc – Key Employee Biographies
21st Century Oncology Inc – Major Products and Services
21st Century Oncology Inc – History
21st Century Oncology Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
21st Century Oncology Inc – Business Description
21st Century Oncology Inc – SWOT Analysis
SWOT Analysis – Overview
21st Century Oncology Inc – Strengths
21st Century Oncology Inc – Weaknesses
21st Century Oncology Inc – Opportunities
21st Century Oncology Inc – Threats
21st Century Oncology Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
21st Century Oncology Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 14, 2019: 21st Century Oncology bolsters its best-in-class Oncology dream team by adding five nationally renowned physicians
Jan 07, 2019: 21st Century Oncology hires Powell as chief operating officer
Apr 18, 2018: 21st Century Oncology Names Kimberly Commins-Tzoumakas As Chief Executive Officer
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
21st Century Oncology Inc, Key Facts
21st Century Oncology Inc, Key Employees
21st Century Oncology Inc, Key Employee Biographies
21st Century Oncology Inc, Major Products and Services
21st Century Oncology Inc, History
21st Century Oncology Inc, Other Locations
21st Century Oncology Inc, Subsidiaries
21st Century Oncology Inc, Key Competitors
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
21st Century Oncology Inc, Recent Deals Summary

List of Figures
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[21st Century Oncology Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • FibroGen Inc (FGEN):企業財務及び戦略的SWOT分析
    Summary FibroGen Inc (FibroGen) is a pharmaceutical company that discovers, develops and commercializes new therapeutics. The company’s pipeline portfolio products include roxadustat (FG-4592), an oral small molecule inhibitor of HIF prolyl hydroxylases that is used for the treatment of anemia in ch …
  • J Trust Co., Ltd.:企業の戦略・SWOT・財務分析
    SummaryJ Trust Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Roxi Petroleum PLC (RXP):企業概要、財務及び戦略的SWOT分析
    Summary Roxi Petroleum PLC (Roxi) is an oil and gas exploration and production company. The company explores and produces crude oil and natural gas in Central Asia. It holds assets in exploration and production contract areas, such as petroleum basins including the Pre-Caspian basin and the Mangyshl …
  • Rosseti (RSTI):企業の財務・戦略的SWOT分析
    Rosseti (RSTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • PT Rekayasa Industri:企業の戦略的SWOT分析
    PT Rekayasa Industri - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Jubilee General Insurance Company Limited:企業の戦略・SWOT・財務分析
    SummaryJubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view o …
  • JSC Polymetal:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JSC Polymetal Mergers and Acqui …
  • Definiens AG:医療機器:M&Aディール及び事業提携情報
    Summary Definiens AG (Definiens), a subsidiary of AstraZeneca Plc, is a healthcare technology company that offers image analysis and data mining solutions. The company offers products such as tissue studio, developer, image miner, server, architect and viewer, among others. Its services include cons …
  • Hokuto Bank Ltd:企業の戦略・SWOT・財務情報
    Hokuto Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Hokuto Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Bone Biologics, Corp.:企業のM&A・提携動向(医療機器分野)
    Summary Bone Biologics, Corp. (Bone Biologics) is a convergence biotechnology company that develops and manufactures bone regeneration technologies. The company offers University of California Bone-1 (UCB-1) technology, a target-specific recombinant human protein that recapitulates normal human grow …
  • Nexeon MedSystems Inc-医療機器分野:企業M&A・提携分析
    Summary Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes therapies and devices for the treatment of cardiovascular diseases. The company’s products categories include nanotechnology-based devices, embolic protection systems, local drug and biologic delivery …
  • AV Homes, Inc. (AVHI):企業財務及び戦略的SWOT分析
    Summary AV Homes, Inc. (AV Homes) is a construction company that offers home building, community development and real estate operations. The company offers services such as acquisition, development, building of active adult and conventional home communities and construction and sale of residences, a …
  • Cosan Ltd:企業の戦略・SWOT・財務情報
    Cosan Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosan Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Transgene SA (TNG):企業のM&A・提携動向(医療分野)
    Summary Transgene SA (Transgene) is a biopharmaceutical company that focuses on the discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company’s lead clinical stage programs include TG4010, which is intended for the treatment of non small cell lung cance …
  • BBB Technologies Inc:企業の製品パイプライン分析2018
    Summary BBB Technologies Inc (BBB Tech) is a development stage medical technology company that develops medical devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. The company discovers and develops single-drop and mobile integrated diagnostic tool …
  • Kamei Corporation (8037):企業財務及び戦略的SWOT分析
    Summary Kamei Corporation (Kamei) is a general trading company that offers diversified services. The company’s business includes corporate sales, residential, carlife, food, construction materials, and pharmacy divisions. It provides eco-friendly products, including LED lighting, eco pumps, and warm …
  • Eco2 Ltd:企業のM&A・提携動向(エネルギー分野)
    Summary Eco2 Ltd (Eco2) is a renewable energy company that develops, finances and operates renewable energy projects. The company generates electricity from wind. It manages fuel logistics and administration of Western Wood Energy Plant, which is wood fired project located in Port Talbot, South Wale …
  • Eisai Co Ltd (4523):企業のM&A・提携動向(医療機器分野)
    Summary Eisai Co Ltd (Eisai) is one of the leading pharmaceutical companies in Japan. It undertakes the research, development, manufacture and marketing of pharmaceuticals, including over-the-counter (OTC) drugs and pharmaceutical production systems, besides chemicals, food ingredients and additives …
  • McKinsey and Company, Inc.:企業の戦略・SWOT・財務分析
    SummaryMcKinsey and Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • CITIC Resources Holdings Limited:企業の戦略・SWOT・財務情報
    CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆